Kubica, J., Adamski, P., Gorog, D. A., Kubica, A., Jilma, B., Budaj, A., … Navarese, E. P. (2022). Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial. Cardiol J, 29(1), 148–153. https://doi.org/10.5603/CJ.a2021.0118

Kubica, Jacek, Piotr Adamski, Diana A. Gorog, Aldona Kubica, Bernd Jilma, Andrzej Budaj, Jolanta M. Siller-Matula, et al. “Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial.” Cardiol J 29, no. 1 (2022): 148–53. https://doi.org/10.5603/CJ.a2021.0118.

Kubica J, Adamski P, Gorog DA, Kubica A, Jilma B, Budaj A, et al. Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial. Cardiol J. 2022;29(1):148–53.

Kubica, Jacek, et al. “Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial.” Cardiol J, vol. 29, no. 1, 2022, pp. 148–53. Pubmed, doi:10.5603/CJ.a2021.0118.

Kubica J, Adamski P, Gorog DA, Kubica A, Jilma B, Budaj A, Siller-Matula JM, Gurbel PA, Alexopoulos D, Badarienė J, Dąbrowski P, Dudek D, Giannitsis E, Horszczaruk G, Jaguszewski MJ, James S, Jeong Y-H, Kryjak M, Niezgoda P, Ostrowska M, Patti G, Romanek J, Di Somma S, Specchia G, Tantry U, Gąsior M, Tycińska A, Wojakowski W, Buszko K, Gil R, Gruchała M, Kasprzak J, Kleinrok A, Legutko J, Lesiak M, Navarese EP. Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial. Cardiol J. 2022;29(1):148–153.